Mėmelio klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 132,231 | 291,908 | 257,492 | 389,149 | 352,025 | 368,107 | 365,216 | 255,112 |
| Profit before tax | - | - | - | - | - | - | 86,038 | -20,669 |
| Net profit | 23,151 | 49,239 | 11,781 | 36,564 | 85,288 | 71,315 | 74,052 | -20,669 |
| Equity | 12,064 | 61,302 | 73,090 | 109,655 | 194,943 | 166,258 | 2,500 | -18,169 |
| Liabilities | 29,659 | 27,490 | 26,266 | 70,066 | 9,877 | 124,317 | 90,961 | 79,899 |
| Non-current assets | 5,496 | 1,554 | 13,989 | 29,174 | 16,420 | 9,909 | 8,502 | 32,940 |
| Current assets | 34,350 | 86,792 | 85,123 | 150,132 | 187,996 | 277,260 | 82,026 | 25,905 |
| Total assets | 39,846 | 88,346 | 99,112 | 179,306 | 204,416 | 287,169 | 90,528 | 58,845 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 42,760 | 79,711 | 45,432 |
| Social insurance contributions | - | - | - | - | - | 27,697 | 28,890 | 25,592 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +104.3% | +120.8% | -11.8% | +51.1% | -9.5% | +4.6% | -0.8% | -30.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 58.1% | 55.7% | 11.9% | 20.4% | 41.7% | 24.8% | 81.8% | -35.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 191.9% | 80.3% | 16.1% | 33.3% | 43.8% | 42.9% | 2962.1% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.5% | 16.9% | 4.6% | 9.4% | 24.2% | 19.4% | 20.3% | -8.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 23.6% | -8.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.5 | 0.4 | 0.4 | 0.6 | 0.1 | 0.7 | 36.4 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 10,043 | 22,170 | 16,263 | 22,132 | 34,344 | 50,197 | 50,960 | 38,975 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mėmelio klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-02 | 2023-05-03 | 0.01 |
| 2023-04-18 | 2023-04-28 | 0.01 |
| 2022-09-16 | 2022-09-27 | 3.39 |
| 2022-04-19 | 2022-05-02 | 630.00 |
| 2021-11-16 | 2021-12-06 | 0.01 |
| 2021-10-18 | 2021-11-08 | 0.01 |
Mėmelio klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-04 | 2025-07-20 | 174.47 |
| 2025-07-01 | 2025-07-03 | 1904.31 |
| 2025-04-03 | 2025-04-04 | 411.3 |
| 2025-04-02 | 2025-04-02 | 81.3 |
| 2025-03-30 | 2025-04-01 | 81.24 |
| 2025-03-26 | 2025-03-29 | 80.22 |
| 2025-03-07 | 2025-03-07 | 411.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Memelio klinika, UAB (code 304069388) is a Private Limited Liability Company operating in medical specialists activities. In the latest financial year, 2025, the company generated revenue of €255.1K, down 30.1% year on year and 30.7% below the 2023 level of €368.1K. Profitability weakened materially: net profit fell from €71.3K in 2023 and €74.1K in 2024 to a net loss of €20.7K in 2025, with the profit margin turning to -8.1%. The balance sheet also deteriorated, with total assets declining to €58.8K from €90.5K in 2024 and €287.2K in 2023. Equity moved from €166.3K in 2023 to €2.5K in 2024 and then to -€18.2K in 2025, while liabilities stood at €79.9K. Long-term assets increased to €32.9K in 2025, compared with €8.5K in 2024, while short-term assets were €25.9K. Asset turnover remained high at 4.34x, and revenue per employee was €42.5K, but profit per employee was negative. Leverage and return ratios are distorted by the very small and negative equity base in 2025.